NEW YORK (360Dx) – Lunaphore Technologies has partnered with Vitro to develop in situ hybridization (ISH) protocols for RNA and DNA targets in tissue, the companies announced today.

Under the terms of the deal, the partners will develop the protocols using Vitro reagents on Lunaphore's microfluidics-based rapid autostaining platform, which is currently in the prototype stage. Additional terms were not disclosed.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.